Evaluating current formulary access for the 25 drugs selected for Drug Price Negotiation in Medicare Part D shows several selected drugs have ...
This year, people on Medicare Part D will not have to pay more than $2,000 in out-of-pocket drug expenditures — and that ...
Show financial editor Jean Chatzky has some major thoughts for Americans on Medicare, particularly about simplifying the ...
A century ago, Argentina was one of the richest countries in the world. Then the Great Depression hit, the bubble popped, and ...
During last year’s enrollment period, millions of Medicare beneficiaries reviewed their coverage options and selected new ...
Just before the inauguration, the outgoing Biden administration announced 15 new medications that’ll be subject to government ...
America’s senior population is the largest it has ever been and is predicted to nearly double by 2050. To meet the needs of ...
Physicians treating Medicare patients are staring down the barrel of five consecutive years of cuts to their reimbursement ...
Medicare Part A (hospital insurance ... more concerned about stagflation-- a combination of slow growth and higher inflation -- than they are about a recession. However, stagflation that causes ...
Talks between CMS and drugmaker Amgen authorized under the Inflation Reduction Act (IRA), former President Biden's signature legislative success, led to an agreement that Medicare would pay $2,355 ...
Inflation is the tendency for prices of goods ... like medical care paid for by employer-provided insurance or Medicare and Medicaid. CPI doesn’t keep up with these in-direct expenses.